Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance.
- NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_assertion description "[High-level amplification of EIF3S3 was found in 11 of 125 (9%) of pT1/pT2 tumors, 12 of 44 (27%) of pT3/pT4 tumors, and 8 of 37 (22%) of lymph node metastases as well as in 26 of 78 (33%) and 15 of 30 (50%) of hormone refractory locally recurrent tumors and metastases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance.
- NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_assertion evidence source_evidence_literature NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance.
- NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_assertion SIO_000772 11733359 NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance.
- NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_assertion wasDerivedFrom befree-20150227 NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance.
- NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_assertion wasGeneratedBy ECO_0000203 NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance.
- befree-20150227 importedOn "2015-02-27" NP801677.RA_5b4OcMu9o0J-wrNOueGSqyKPIsVhT5FDZYJvFET1-Y130_provenance.